Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

252results about "Aminosugars" patented technology

Method for removing lactulose-based isomer in oligosaccharide separation and purification process

The invention relates to the technical field of biology, and particularly discloses a method for removing lactulose-based isomers in an oligosaccharide separation and purification process. The method comprises the following steps: taking oligosaccharide fermentation liquor for producing oligosaccharide through fermentation by using lactose as a substrate, sequentially carrying out thallus removal, decoloration, electrodialysis desalination, ion exchange resin desalination, concentration, sequential simulated moving bed chromatographic purification, ultrafiltration, re-concentration and spray drying, and detecting the oligosaccharide and the lactulose-based isomer in the oligosaccharide. According to the method disclosed by the invention, the content of lactulose-based isomers in the separation and purification process is greatly reduced, so that the product purity is effectively improved; the method can be applied to the synthesis process of other milk oligosaccharides such as fucose lactose (FL), lactose-N-tetraose (LNT), lactose-N-neotetraose (LNnT), lactose-N-fucopentasaccharide (LNPFI) and the like or other carbohydrates containing a lactosyl group, has a very high application value, and accords with laws and regulations.
Owner:HEFEI INSTITUTE OF PHYSICAL SCIENCE CHINESE ACADEMY OF SCIENCES

Glutamic acid derivative as well as preparation method and application thereof in rhythm gene regulation and oxidation resistance

The invention relates to the technical field of oxidation resistance, in particular to a glutamic acid derivative, a preparation method thereof and application of the glutamic acid derivative in rhythm gene regulation and oxidation resistance. The glutamic acid derivative has a structure as shown in a formula I. The glutamic acid derivative provided by the invention can up-regulate expression of CLOCK protein and Per3 protein, can inhibit ROS in cells and up-regulate expression of Nrf2, and can be applied to relieving skin problems caused by disorder of circadian rhythm. # imgabs0 #
Owner:HUNAN YUJIA COSMETICS MFG CO LTD

Polystyrene cation exchange resin as well as preparation method and application thereof

The invention relates to polystyrene cation exchange resin as well as a preparation method and application thereof. The preparation method comprises the following steps: dissolving a dispersing agent in a solvent to obtain a dispersed phase for suspension polymerization reaction, uniformly mixing a reaction monomer, a cross-linking agent, a pore-foaming agent and an initiator, and carrying out suspension polymerization reaction under segmented stirring and segmented temperature change to prepare copolymer microspheres; and putting the dried microspheres into a reaction kettle, swelling, carrying out sulfonation reaction through a variable temperature program on the basis to obtain sulfonated microspheres, and carrying out alkali exchange reaction on the sulfonated microspheres to obtain the final product cation exchange resin. Compared with the prior art, the cation exchange resin preparation method provided by the invention has the characteristics of simple and feasible process, easiness in large-scale production, low cost, high specific surface area, high adsorption capacity and high separation efficiency, and is especially suitable for separating and purifying substances containing amino groups or aminoglycosidic bonds.
Owner:EAST CHINA UNIV OF SCI & TECH +1

Escherichia coli BL21 star (DE3) BLBRTXST3 and method for producing high-purity lactose-N-neotetraose by fermentation and application thereof

A method and application of Escherichia coli BL21star (DE3) BLBRTXST3 and its fermentation method for producing high-purity lactose-N-neotetraose, the invention relates to the technical field of human milk oligosaccharide production, Escherichia coli )BL21 star (DE3) BLBRTXST3 is deposited in the General Microbiology Center of China Microorganism Culture Collection Committee, with the deposit number CGMCC No. 32521 and the deposit date November 6, 2024. The address of the deposit institution is No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing; Escherichia coli ( Escherichia coli )BL21 star (DE3) BLBRTXST3 is used in the fermentation production of lactose-N-neotetraose (LNnT). The present invention improves the yield of lactose-N-neotetraose, uses a chromatographic simulated moving bed to produce high-purity lactose-N-neotetraose with a purity greater than 94%, replaces the traditional solvent crystallization method, has simple separation and purification, is conducive to industrial production, and simultaneously produces linear lactose-N-neohexaose with a purity greater than 95%.
Owner:BAOLINGBAO BIOLOGY

Potent asgpr-binding compounds for the degradation of immunoglobulins and other proteins

Extracellular protein degraders and compositions are provided that have a potent asialoglycoprotein receptor (ASGPR) Binding Ligand bound to an Extracellular Protein Targeting Ligand for the selective degradation of the Target Extracellular Protein, for example immunoglobulin in vivo to treat disorders mediated by the extracellular protein.
Owner:AVILAR THERAPEUTICS INC

Amphiphilic polymer ly0016, and synthesis and use thereof

An amphiphilic polymer LY0016, which has the chemical structure as shown in the following formula (I), a method for preparing same, and the use thereof in the preparation of a pharmaceutical preparation comprising a drug active molecule. The drug active molecule comprises, but is not limited to, a small molecule compound, a peptide analogue, a polypeptide or an antigen, a protein, an antibody and an immunologic adjuvant.
Owner:BEIJING LIANGYUAN BIO-SCI LLC

Method for purifying 6-sialyllactose

The invention relates to the technical field of biology, in particular to a method for purifying 6-sialic acid lactose. According to the 6-sialic acid lactase reaction liquid prepared based on multi-enzyme catalysis, the high-efficiency, high-purity and high-recovery-rate purification method of the 6-sialic acid lactase is developed by combining membrane separation and simulated moving bed chromatography technologies, meanwhile, less wastewater is generated, the cost benefit is high, and continuous large-scale production can be achieved.
Owner:SHENZHEN READLINE BIOTECH CO LTD

Azobenzene calix [4] arene derivative as well as preparation method and application thereof

The invention belongs to the technical field of pesticides, and particularly relates to azobenzene calix [4] arene derivatives as well as a preparation method and application thereof. The invention discloses a novel azobenzene calix [4] arene derivative prepared by directional modification through an azo reduction reaction based on a calix [4] arene skeleton. The azobenzene calix [4] arene derivative has the characteristics of green environmental protection, accurate and controllable structure and efficient synthesis. After the derivative and a pesticide form a host-guest compound, the activity of the pesticide can be remarkably improved, the bioavailability of the pesticide at an action site is increased, the problem of low efficiency of the traditional pesticide is effectively solved, and the development of target drug resistance is delayed. The technology breaks through the technical bottleneck of nano-carrier environmental toxicity, provides a new thought for developing a multi-target and low-environmental-risk pesticide synergist, and has important significance for realizing pesticide decrement, synergism and resistance treatment.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Turbine engine airway cleaning agent, preparation method thereof and cleaning solution

The invention relates to the technical field of cleaning solutions, in particular to a turbine engine airway cleaning agent, a preparation method thereof and a cleaning solution, and the cleaning agent comprises the following components in percentage by mass: 6-10% of 2, 4, 7, 9-tetramethyl-5-decyne-4, 7-glycol polyoxyethylene ether, 3-5% of a multifunctional additive, 0.5-1% of a corrosion inhibitor and 84-90.5% of deionized water. According to the invention, the ash-free nonionic surfactant 2, 4, 7, 9-tetramethyl-5-decyne-4, 7-glycol polyoxyethylene ether has emulsification and permeation wetting functions, has emulsification and stripping functions on semi-solid oil sludge containing carbon deposition, and has a synergistic decontamination effect with the multifunctional auxiliary agent, and the multifunctional auxiliary agent contains an amide group, so that the multifunctional cleaning agent has a good cleaning effect on the semi-solid oil sludge containing carbon deposition. The metal corrosion inhibitor can be adsorbed on the metal surface or coordinated with metal ions on the metal surface to form a layer of isolating membrane to protect metal, has a synergistic effect with the corrosion inhibitor, only generates carbon dioxide, hydrogen nitride gas and water vapor after combustion, and does not contain ash such as inorganic salt or metal oxide.
Owner:LUHOPE ADVANCED MATERIALS TECH CO LTD

TLR4 agonist, application thereof and vaccine composition

The invention relates to the technical field of medicinal chemistry, and provides a TLR4 agonist, application thereof and a vaccine composition. The TLR4 agonist is a compound with a structure as shown in a formula 1 or a pharmaceutically acceptable salt thereof, the compound is glucosamine aminoalkyl 4-phosphate series molecules derived from MPL-12 structure modification, and the series molecules have enhanced immunostimulatory activity and selective immune response induction capability.
Owner:HUAZHONG NORMAL UNIV

Bifunctional molecules for degrading circulating proteins

PendingJP2025509736AOrganic active ingredientsSugar derivativesMacrophage migration inhibitionAutoimmune condition
Described herein are bifunctional compounds for removing macrophage migration inhibitory factor (MIF) or immunoglobulin G (IgG). Further described herein are pharmaceutical compositions comprising these bifunctional compounds. Further described herein are methods for treating pathologies and / or conditions with said compounds or compositions. The pathologies and / or conditions are mediated through MIF / IgG or where MIF / IgG is a contributing factor in the development and perpetuation of diseases and / or conditions, such as autoimmune diseases and cancers, among others. TIFF2025509736000504.tif99145
Owner:YALE UNIVERSITY

Supramolecular amino-oligosaccharide, nano preparation containing supramolecular amino-oligosaccharide and preparation method and application of nano preparation

The invention relates to the technical field of pesticide preparation processing, in particular to supramolecular amino-oligosaccharide, a nano preparation containing the supramolecular amino-oligosaccharide and a preparation method and application of the supramolecular amino-oligosaccharide. The supramolecular amino-oligosaccharide is provided, and the supramolecular amino-oligosaccharide is obtained by combining amino-oligosaccharide with water molecules or hydrogen peroxide molecules through acid; wherein amino groups in the amino-oligosaccharide and carboxyl groups of acid can be subjected to an acid-base reaction to form chemical bonds such as amido bonds, meanwhile, water molecules or hydrogen peroxide molecules participate in the reaction process, hydrogen atoms in the water molecules or the hydrogen peroxide molecules and atoms such as nitrogen and oxygen in the amino-oligosaccharide or acid molecules can form hydrogen bonds, and the structure of the molecules can be stabilized; therefore, the overall charge state of the formed supramolecular amino-oligosaccharide is more stable, it is ensured that the amino-oligosaccharide is stable and not prone to being decomposed in the compounding process, the pesticide effect of the supramolecular amino-oligosaccharide can be effectively exerted, and application is promoted.
Owner:SHENZHEN NOPOSION AGROCHEM CO LTD

Biobased compounds for polymer production

A polymeric material comprising a base monomer and a multifunctional biobased molecule wherein the multifunctional biobased molecule is a glucose derivative. A polymeric material comprising a base polymer and a polymeric additive comprising glucaric acid, glucodialdose, gluconic acid, erythorbic acid, 2-ketoglucose, lactic acid, adipic acid, sorbitol, glycerol, mannitol, lactones thereof, salts thereof, or combinations thereof wherein the additive when introduced to a base polymer forms a modified polymer wherein the modified polymer has a tensile strength that is increased by from about 10% to about 100% wherein compared to the base polymer.
Owner:SOLUGEN INC

Method for producing oligosaccharide having lewis x skeleton

The present invention relates to a microorganism having an enhanced activity of a protein according to any one of the following [1] to [4] and improved productivity of an oligosaccharide having a Lewis X skeleton as compared with a parent strain: [1] a protein consisting of the amino acid sequence represented by SEQ ID NO: 2, [2] a mutant protein having an α1,3-fucosyl transferase activity and consisting of an amino acid sequence in which 1 to 20 amino acids are deleted, substituted, inserted, or added in the amino acid sequence represented by SEQ ID NO: 2, [3] a homologous protein having an α1,3-fucosyl transferase activity and consisting of an amino acid sequence having an identity of 90% or more with the amino acid sequence represented by SEQ ID NO: 2, and [4] a protein consisting of the amino acid sequence represented by SEQ ID NO: 24, 18, or 26.
Owner:KIRIN HOLDINGS KK

Carboxylate compound reduction method

The invention provides a reduction method of a carboxylic ester compound. The method comprises the following steps: in a solvent, under the conditions of a phenol catalyst, alkali, an additive and illumination, carrying out a reduction reaction on a compound containing a fragment I and a hydrogen source to obtain a compound containing a fragment II. The preparation method disclosed by the invention is high in yield, few in by-products, wide in substrate application range, good in functional group compatibility and mild in reaction condition.
Owner:YUNNAN UNIV

Chitosan oligosaccharide unsaturated fatty acid salt derivative as well as preparation method and application thereof

The invention relates to the technical field of functional food, medicine and health care, and particularly discloses a chitosan oligosaccharide unsaturated fatty acid salt derivative and a preparation method and application thereof.The chitosan oligosaccharide unsaturated fatty acid salt derivative is a compound shown in the formula (1), and the preparation method comprises the specific preparation steps that chitosan oligosaccharide and unsaturated fatty acid are subjected to an ionic reaction, and the chitosan oligosaccharide unsaturated fatty acid salt derivative is obtained. The chitosan oligosaccharide unsaturated fatty acid salt derivative shown in the formula (1) is prepared, and the molar ratio of chitosan oligosaccharide to unsaturated fatty acid is 1: 1-1: 3. According to the derivative, chitosan oligosaccharide with excellent biocompatibility is used as a framework, and an unsaturated fatty acid group is combined to 2-position amino positive ions of the chitosan oligosaccharide in a zwitterion combination mode, so that the chitosan oligosaccharide unsaturated fatty acid salt derivative is prepared. The derivative has the characteristics of two compounds of chitosan oligosaccharide and unsaturated fatty acid at the same time, and can remarkably inhibit the activity of alpha-glucosidase, so that the effect of assisting in reducing blood sugar is achieved.
Owner:JIANGSU OCEAN UNIV +1

Anti-tumor composition containing N-acetyl-D-glucosamine and preparation method thereof

The invention discloses an anti-tumor composition containing N-acetyl-D-glucosamine and a preparation method of the anti-tumor composition in the field of anti-tumor preparations. The anti-tumor composition comprises the following components in parts by weight: 1-3 parts of functionalized N-acetyl-D-glucosamine and 3-5 parts of a polypeptide modifier. Through polypeptide modification and application of the N-acetyl-D-glucosamine, the N-acetyl-D-glucosamine (GlcNAc) as a bioactive sugar molecule can possibly have the following effects in tumor microenvironment regulation and control through the immune regulation function of the N-acetyl-D-glucosamine; glycometabolism interference: cancer cells usually grow rapidly depending on the Warburg effect, and the functionalized N-acetyl-D-glucosamine can inhibit proliferation of the cancer cells by influencing the glycometabolism of the cancer cells, and can synergistically play an anti-tumor role in three directions of glycometabolism interference, immunoregulation and cell apoptosis induction.
Owner:董淑霞 +1

Method for quantifying chitosan and method for preparing sample used for quantitative analysis of chitosan by high performance liquid chromatography

To provide a method for quantifying chitosan and a method for preparing a sample used for quantitative analysis of chitosan by high performance liquid chromatography, which enable accurate quantification of chitosan content in food through simple operation.SOLUTION: A method for quantifying chitosan comprises a dissolution step in which chitosan contained in a food is dissolved in an acidic aqueous solution, an enzymatic degradation step of enzymatically degrading the chitosan using chitosanase, an acid degradation step of degrading the chitosan into glucosamine using an acid, and a quantification step of quantifying the glucosamine by high performance liquid chromatography to quantify the chitosan content.SELECTED DRAWING: None
Owner:NIPPON KAYAKU FOOD TECHNO CO LTD +1

Method for producing oligosaccharide having lewis x skeleton

The present invention relates to a microorganism having an enhanced activity of a protein according to any one of the following [1] to [4] and improved productivity of an oligosaccharide having a Lewis X skeleton as compared with a parent strain: [1] a protein consisting of the amino acid sequence represented by SEQ ID NO: 2, [2] a mutant protein having an α1,3-fucosyl transferase activity and consisting of an amino acid sequence in which 1 to 20 amino acids are deleted, substituted, inserted, or added in the amino acid sequence represented by SEQ ID NO: 2, [3] a homologous protein having an α1,3-fucosyl transferase activity and consisting of an amino acid sequence having an identity of 90% or more with the amino acid sequence represented by SEQ ID NO: 2, and [4] a protein consisting of the amino acid sequence represented by SEQ ID NO: 24, 18, or 26.
Owner:KIRIN HOLDINGS KK

Galactosamine-doxetaxel conjugate, and preparation method and application thereof

ActiveCN117645637BHighly effective in killing tumor cellsEsterified saccharide compoundsOrganic active ingredientsPropanoic acidSialic acid
The application belongs to the technical field of biological medicine, and particularly relates to a galactosamine-doxetaxel conjugate as well as a preparation method and application thereof. First, doxetaxel and 3,3'-diseleno-dipropionic acid are used as raw materials, and after heating reaction, 3,3'-diseleno-dipropionic acid doxetaxel is obtained. Then, the obtained 3,3'-diseleno-dipropionic acid doxetaxel and galactosamine are used as raw materials, and after heating reaction, galactosamine-3,3'-diseleno-dipropionic acid doxetaxel conjugate is obtained through column chromatography separation and purification. The obtained conjugate can be specifically recognized by endogenous lectin receptors (such as asialoglycoprotein receptor ASGPR) which are highly expressed on the surface of hepatoma cells, so as to be taken up by hepatoma cells through a receptor-mediated pathway, and has application prospect in the direction of hepatoma targeted treatment.
Owner:CHANGZHOU UNIV

Cross-linking agent with mass spectrum fragmentable trehalose disaccharide as skeleton structure and preparation and application thereof

PendingCN121824643AEsterified saccharide compoundsSugar derivativesHydroxylamineProtein protein interaction network
The invention relates to a novel chemical cross-linking agent with mass spectrum fragmentable trehalose disaccharide as a skeleton structure and a preparation method thereof. The cross-linking agent disclosed by the invention has the following characteristics: 1) trehalose disaccharide is used as a skeleton structure, so that the cross-linking agent has excellent biocompatibility; 2) the trehalose skeleton has a pair of symmetrical mass spectrum fragmentable glucosidic bonds, so that a cross-linked peptide fragment can be simplified into a conventional peptide fragment modified by a cross-linking agent fragment; 3) the enrichment of the cross-linked peptide fragment can be realized by the trehalose skeleton under the condition of not adding an enrichment handle; and 4) active groups of the cross-linking agent comprise but not limited to a plurality of reactive groups such as succinamide ester, diaziridine, phenylsulfonyl fluoride, hydrazide group, amino group, hydroxylamine group and the like, and chemical cross-linking of a plurality of amino acids except lysine is realized. The trehalose cross-linking agent disclosed by the invention is applied to the field of proteomics, and provides technical support for realizing large-scale analysis of a protein complex in a complex sample, spatial structure analysis of protein and a protein-protein interaction network.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES

Partially acylated non-natural sugar for metabolic labeling and application of partially acylated non-natural sugar

The invention discloses a partial acylated non-natural sugar for metabolic labeling and application, the partial acylated non-natural sugar is a mannose type of a pyranose structure, and 1-hydroxyl and 6-hydroxyl are protected by hydrophobic groups. According to the method, the advantages of existing non-natural sugar are taken into consideration, it is guaranteed that the non-natural sugar can be efficiently utilized by cells, S side reaction of the non-natural sugar and cysteine in protein in the metabolism process is effectively avoided, and meanwhile efficient metabolism marking is achieved. In a cell test, the use concentration of the 1, 6-diacylated non-natural sugar is one order of magnitude lower than that of the non-natural sugar without the protecting group.
Owner:LINXCELL BIOTECHNOLOGIES

Production process of N-acetylglucosamine

The invention discloses a production process of N-acetylglucosamine, and belongs to the technical field of N-acetylglucosamine production. Methanol is used as a solvent, glucosamine hydrochloride and acetic anhydride are used as raw materials, sodium hydroxide is added as a catalyst, other toxic chemical substances are not introduced, and meanwhile, the product yield is increased. In addition, in the product purification treatment process, a specific fixing agent is added, the specific fixing agent is a magnetic nanoparticle immobilized phenylboronic acid derivative, and the phenylboronic acid derivative can recognize and combine D-glucosamine with cis-dihydroxyl and cannot react with N-acetylglucosamine; the D-glucosamine in the N-acetylglucosamine can be effectively and selectively removed; and after the magnetic nanoparticles are immobilized, the selective adsorption reaction can be amplified, the separation and removal are facilitated, and the operation steps are simplified.
Owner:TAIZHOU CITY FENGRUN BIOCHEM